Balanced news tone
News Sentiment
GILD sentiment intelligence
Gilead Sciences, Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
87/100 classification confidence.
directly relevant articles
high-authority source matches
-4.5% over one week, +9.0% over four weeks, trend inactive, and materially above fair value.
Gilead Sciences (GILD) Sees a More Significant Dip Than Broader Market: Some Facts to Know
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Gilead Sciences (GILD) Sees a More Significant Dip Than Broader Market: Some Facts to Know
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jul 2026 22:00
- Source
- Market source
Gilead Sciences Inc (GILD) Stock Up 3.5% but GF Value Says Overv
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jul 2026 21:35
- Source
- GuruFocus
Gilead Sciences (NASDAQ: GILD) exec trades 3,000 shares under 10b5-1 plan
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jul 2026 20:55
- Source
- Stock Titan
Planned 3,000-share sale by Gilead (NASDAQ: GILD) shareholder Johanna Mercier
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jul 2026 20:13
- Source
- Stock Titan
Gilead Sciences, Inc. (GILD) Stock Analysis: Promising 21.93% Upside Amid Strong Buy Ratings
- Tone
- Positive 95/100
- Event
- Market update
- Published
- 13 Jul 2026 09:12
- Source
- DirectorsTalk Interviews
Gilead Sciences (GILD) Stock Dips While Market Gains: Key Facts
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 10 Jul 2026 22:00
- Source
- Market source
Gilead (GILD) Stock Looks Below Fair Value But Earnings Already Look Priced In
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 09 Jul 2026 07:00
- Source
- simplywall.st
Will Trodelvy’s First-Line TNBC Approval Redefine Gilead Sciences’ (GILD) Oncology-Led Investment Narrative?
- Tone
- Neutral 50/100
- Event
- Regulatory and legal
- Published
- 26 Jun 2026 07:00
- Source
- Market source
Could This FDA Milestone Unlock Gilead’s (GILD) Next Big Growth Driver?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 22 Jun 2026 07:00
- Source
- Market source
Gilead Sciences Stock (GILD) Opinions on Recent Congressional Insider Activity
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 Jun 2026 07:00
- Source
- Quiver Quantitative
Gilead Sciences (GILD) Stock Falls Amid Market Uptick: What Investors Need to Know
- Tone
- Negative 22/100
- Event
- Market update
- Published
- 15 Jun 2026 07:00
- Source
- Market source
Assessing Gilead Sciences (GILD) Valuation After Recent Share Price Weakness
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Jun 2026 07:00
- Source
- Market source
Is It Time To Reassess Gilead Sciences (GILD) After Strong Multi Year Share Price Gains
- Tone
- Positive 82/100
- Event
- Market update
- Published
- 23 May 2026 07:00
- Source
- Market source
Gilead Sciences (GILD) Stock: Surges as FDA Approves First U.S. Treatment for Hepatitis Delta
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 22 May 2026 07:00
- Source
- parameter.io
Gilead Sciences Just Told Investors What to Watch Before December 23. Here’s What the Data Says About GILD Stock.
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 May 2026 07:00
- Source
- TIKR.com
Gilead Sciences (GILD) Stock Dips Despite Q1 Beat as $11.5B Acquisition Charges Slash Annual Outlook
- Tone
- Positive 66/100
- Event
- Deals and strategy
- Published
- 08 May 2026 07:00
- Source
- parameter.io
Gilead Sciences Inc. (GILD): Growing Popularity as Defensive Stock
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 Apr 2026 07:00
- Source
- Market source
Gilead Sciences Deploys $16 Billion in 60 Days: Is GILD Stock Undervalued for 2026?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 21 Apr 2026 07:00
- Source
- TIKR.com
Gilead Sciences (GILD) Stock Declines While Market Improves: Some Information for Investors
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 05 Jan 2026 08:00
- Source
- Market source
Gilead Hit With Downgrades on Questions of Remdesivir Profit
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 01 May 2020 07:00
- Source
- Bloomberg.com